Neurological disorders impact up to a billion people around the world. There are various neurological conditions found which affect the different parts of brain. The most important neurological disorders are dementia, epilepsy, headache disorders, multiple sclerosis, and neuro infections, neurological disorders associated with malnutrition, pain associated with neurological disorders, Parkinson’s disease, stroke and traumatic brain injuries. Cases of neurological is rising globally in both pediatrics and geriatrics population. Hydrocephalus can be associated with various neurological conditions, such as tumors, infections, traumatic brain injuries, and congenital anomalies. As the incidence of these underlying neurological disorders increases, so does the likelihood of hydrocephalus development, driving the demand for its diagnosis and management.
Neurosurgical procedures, including the placement of shunts to manage hydrocephalus, are often necessary for individuals with neurological conditions. There is a corresponding increase in the demand for neurosurgical interventions as the prevalence of neurological disorders rises, contributing to the growth of the hydrocephalus market. Thus, the increasing rate of neurological disorders and conditions is a major driver for the market growth.
Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/global-hydrocephalus-market
Data Bridge Market Research analyzes that the Global Hydrocephalus Market is expected to reach USD 2,592,720.77 thousand by 2031 from USD 1,587,759.20 thousand in 2023, growing with the CAGR of 6.5% in the forecast period of 2024 to 2031.
Key Findings of the Study
Growing Number of Newborns Affected by Hydrocephalus
Hydrocephalus is a medical condition characterized by an abnormal accumulation of Cerebrospinal Fluid (CSF) within the cavities of the brain, leading to increased intracranial pressure. It can be congenital or acquired and may affect individuals of all ages, including newborns. Rising number of pediatric hydrocephalic due to bleeds, brain tumors, head injury and infections as few days before and after birth are a time of risk for stroke in both mother and infant, probably related to activation of coagulation mechanisms in this critical period which is a major driving factor. Hydrocephalus can be congenital, meaning it occurs at birth or shortly afterward. The increasing global birth rate may lead to a higher number of cases of congenital hydrocephalus, driving the demand for medical interventions and treatments associated with the condition.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Type (Congenital Hydrocephalus, Acquired Hydrocephalus, Normal-Pressure Hydrocephalus, and Ex-Vacuo Hydrocephalus), End Users (Hospitals, Clinics, Diagnostic Centers, and Academic Institutions and Research Organizations), Diagnostics & Treatment (Diagnostics and Treatment)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and Rest of Middle East and Africa
|
|
Market Players Covered
|
Integra LifeSciences (U.S.), Aesculap, Inc. – a b. Braun company (U.S.), G.SURGIWEAR LTD (India), Möller Medical GmbH (U.K.), Anuncia Inc (Arizona), CHRISTOPH MIETHKE GMBH & CO. KG (Germany), KARL STORZ SE & Co. KG (Germany), HpBio (Brazil), Medtronic (Ireland), Natus Medical Incorporated (U.S.), Desu Medical (Turkey), Bicakcilar (Turkey), Spiegelberg GmbH & Co. KG (Germany), Sophysa (France), and KANEKA MEDIX CORP (Japan) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework
|
Segment Analysis
The global hydrocephalus market is segmented into three notable segments such as type, diagnostics & treatment, and end users.
- On the basis of type, the market is segmented into congenital hydrocephalus, acquired hydrocephalus, normal-pressure hydrocephalus, and ex-vacuo hydrocephalus. In 2024, the congenital hydrocephalus segment is expected to dominate the market with a market share of 60.86%
- On the basis of diagnostics & treatment, the market is segmented into diagnostics, and treatment
In 2024, the diagnostics segment is expected to dominate the global hydrocephalus market
In 2024, the diagnostics segment is expected to dominate the market with a market share of 62.84% due to the growing pace of early diagnosis of diseases.
- On the basis of end users, the market is segmented into hospitals, clinics, diagnostic centers, and academic institutions and research organizations
In 2024, the hospitals segment is expected to dominate the global hydrocephalus market
In 2024, the hospitals segment is expected to dominate the market with a market share of 58.85% due to the increasing number of hospitals in developed and developing countries.
Major Players
Data Bridge Market Research analyzes Medtronic (Ireland), Aesculap, Inc. – a b. Braun company (U.S.), Integra LifeSciences (U.S.), Spiegelberg GmbH & Co. KG (Germany), and Bicakcilar (Turkey) as market players in global hydrocephalus market.
Market Development
- In July 2023, Luciole Medical AG has declared the acquisition of Spiegelberg GmbH & Co. KG, forming a prominent global developer and provider of brain monitoring solutions. Through the integration of their product suites, manufacturing capabilities, and distribution channels, the companies aim to enhance their strengths and create a unified entity
- In January 2023, the FDA has granted approval for the Medtronic Percept RC neurostimulator featuring the exclusive BrainSense technology. This advancement enables physicians to customize treatment to individualize care for patients with neurological disorders
- In October 2022, Medtronic has announced the introduction of the Medtronic Neurovascular Co-Lab Platform, designed to expedite innovation in the field of stroke treatment
- In June 2022, Integra LifeSciences collaborated with Wipro and Microsoft to design and develop its next-generation data warehouse on Azure Databricks by leveraging Wipro FullStride Cloud Services. Integra solidified its leadership in the medical device industry and expanded the tech maturity of its organization in the faster processing times led to greater agility and the enhanced analytics platform allowed the company to become more customer focused
- In October 2020, Aesculap, Inc. – a b. Braun company and Ascendco Health announced strategic partnership. Ascendco Health is health tech company. This partnership anticipated to strengthen company footprints in market
Regional Analysis
Geographically, the countries covered in the global hydrocephalus market report are U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Ireland, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, Saudi Arabia, South Africa, U.A.E., Israel, Egypt, and Rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
North America is the dominating region in global hydrocephalus market
North America is expected to dominate hydrocephalus market owing to the higher level of investments by various manufacturers and increasing awareness on hydrocephalus in the region.
Asia-Pacific is estimated to be the fastest-growing region in hydrocephalus market the forecast period
Asia-Pacific is estimated to be the fastest-growing due to the presence of major market players and rapid development in healthcare industries in this region. In addition to this, rising strategic initiatives by major market players in the region are expected propel the market's growth rate in this region.
For more detailed information about the global hydrocephalus market report, click here – https://www.databridgemarketresearch.com/fr/reports/global-hydrocephalus-market
